Paper Details 
Original Abstract of the Article :
Treatment with tyrosine kinase inhibitors leads to thyroid dysfunction in up to one half of treated patients, hypothyroidism being the most common. It is caused by destructive thyroiditis, impaired transport of T4 into the cell and deiodinase induction. Bexarotene is a nuclear retinoid X receptor ag...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/27734691

データ提供:米国国立医学図書館(NLM)

Endocrine Complications of Modern Cancer Therapies: Navigating a Complex Landscape

The field of oncology is constantly evolving, with advances in treatment options leading to improved survival rates. However, these treatments often come with potential side effects, including endocrine complications. This research provides a comprehensive overview of endocrine complications associated with modern cancer therapies, highlighting the need for careful monitoring and management.

The authors discuss a range of endocrine side effects associated with various cancer therapies, including tyrosine kinase inhibitors, bexarotene, cytokines, and immune checkpoint inhibitors. They emphasize the importance of recognizing these complications early, as timely diagnosis and management can significantly improve patient outcomes. The study also highlights the crucial role of communication and collaboration between oncologists and endocrinologists to ensure comprehensive patient care.

Navigating the Endocrine Side Effects of Cancer Therapies

This research underscores the importance of being aware of and prepared for the endocrine side effects of modern cancer therapies. The authors' review of the literature highlights the diverse range of complications that can occur, emphasizing the need for vigilant monitoring and prompt intervention. This information is crucial for oncologists and endocrinologists to ensure that patients receive timely and appropriate care.

A Complex Desert: Managing Endocrine Complications

The treatment of cancer is often a complex journey through a desert of challenges. This research serves as a reminder that we must be mindful of the potential for endocrine complications associated with these therapies. By understanding the diverse range of potential side effects and developing effective management strategies, we can help patients navigate this complex terrain and achieve the best possible outcomes.

Dr. Camel's Conclusion

This research provides a valuable guide for navigating the complex desert of endocrine complications associated with modern cancer therapies. By understanding the potential side effects, embracing a vigilant approach to monitoring, and fostering effective communication between oncologists and endocrinologists, we can provide the best possible care for patients undergoing these treatments. The journey towards effective and safe cancer treatment is a continuous one, and this research serves as a vital stepping stone in our collective pursuit of better outcomes for patients.

Date :
  1. Date Completed 2017-06-22
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

27734691

DOI: Digital Object Identifier

59243

Related Literature

SNS
PICO Info
in preparation
Languages

Czech

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.